Skip to main content
. 2023 May 19;13(5):823. doi: 10.3390/brainsci13050823

Table 2.

Comparison of baseline characteristics between patients with depression and without depression.

Variable Without Depression With Depression p-Value
(32) (32)
Sex (male/female) 17/15 11/21 0.13
Age (x ± s) 35.3 ± 13.8 37.0 ± 15.6 0.66
Epilepsy duration M (P25, P75) 6.5 (2.3, 18.3) 9.5 (2.3, 15.0) 0.76
First diagnosis (FD/NFD) 7/25 7/25 1.00
Age at epilepsy diagnosis (x ± s) 26.2 ± 14.0 27.6 ± 14.9 0.70
Epilepsy type (n) 0.15
  Temporal lobe epilepsy (n) 25 16
  Frontal lobe epilepsy (n) 0 2
  Occipital lobe epilepsy (n) 0 1
  Generalized epilepsy (n) 4 7
  Unknown epilepsy (n) 3 6
ASM numbers (n) 0.56
  ≤1 25 23
  ≥2 7 9
ASM types (n)
  CBZ 7 6 0.76
  VA 8 9 0.78
  OXC 6 2 0.26
  LA 7 4 0.32
  PB 1 1 1.00
  TPM 1 5 0.20
  LEV 4 2 0.67
  PNT 1 1 1.00
  CZP 0 5 0.06
HAMD-17 M (P25, P75) 1.0 (0.0, 2.0) 11.5 (9.0, 15.0) 0.00 ***
MMSE M (P25, P75) 28.0 (28.0, 29.0) 29.0 (28.0, 30.0) 0.02 *
DS-forward 8.0 (8.0, 9.0) 8.0 (7.0, 9.0) 0.98
DS-backward 5.6 ± 1.6 4.8 ± 2.2 0.11
VFT-animals 16.9 ± 6.9 15.5 ± 4.9 0.37
SDMT 52.4 ± 6.8 44.6 ± 16.0 0.05
AVLT immediate recall (x ± s) 18.4 ± 6.2 20.4 ± 4.4 0.17
AVLT delayed recall (x ± s) 7.6 ± 3.1 8.5 ± 2.0 0.20
AVLT recognition M (P25, P75) 12.0 (10.5, 12.0) 11.5 (11.0, 12.0) 0.93

Note: FD = first diagnosis, NFD = non-first diagnosis, ASM = antiseizure medicine, VA = valproate, LA = lamotrigine, LEV = levetiracetam, CBZ = carbamazepine, PNT = phenytoin, OXC = oxcarbazepine, CZP = clonazepam, TPM = topiramate, PB = phenobarbitone, HAMD-17 = 17-item Hamilton Depression Rating Scale, MMSE = Mini-Mental State Examination, AVLT = Rey Auditory Verbal Learning Test, DS = digital span, SDMT = Symbol Digit Modalities Test, and VFT = verbal fluency test, * p < 0.05, *** p < 0.001.